Temelimab (formerly GNbAC1)

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: GeNeuro SA […]

Read News Article

Opicinumab

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: Biogen 750 […]

Read News Article

Rituxan® (rituximab)

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: Genentech/Roche Given […]

Read News Article

Aubagio® (teriflunomide)

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]

Read News Article

Lemtrada® (alemtuzumab)

In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References FDA-Approved Medications: New Data on Previously Approved […]

Read News Article